SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049198
Filing Date
2024-04-26
Accepted
2024-04-26 16:26:14
Documents
16
Period of Report
2024-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A xene-20240426.htm   iXBRL DEF 14A 2011247
2 GRAPHIC img254987921_0.jpg GRAPHIC 240987
3 GRAPHIC img254987921_1.jpg GRAPHIC 240987
4 GRAPHIC img254987921_2.jpg GRAPHIC 183221
5 GRAPHIC img254987921_3.jpg GRAPHIC 192365
6 GRAPHIC img254987921_4.jpg GRAPHIC 9737
  Complete submission text file 0000950170-24-049198.txt   4941151

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20240426.xsd EX-101.SCH 37076
19 EXTRACTED XBRL INSTANCE DOCUMENT xene-20240426_htm.xml XML 325041
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36687 | Film No.: 24884236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)